Meet our team

Theme Leads

Professor Sir Peng Tee Khaw

Director, Moorfields Biomedical Research Centre

Professor of Glaucoma and Ocular Healing at the UCL Institute of Ophthalmology and Consultant Ophthalmic Surgeon at Moorfields Eye Hospital, London. He is also Director of Research and Development at Moorfields Eye Hospital; President of the UK Paediatric Glaucoma Society; and an NIHR Senior Investigator since 2009.

Professor Jim Bainbridge

Theme Lead, Gene Therapy

James Bainbridge is a surgeon-scientist dedicated to the development of innovative gene and cell therapies for blinding eye disease. He performed the world's first gene therapy for inherited eye disease, and has established a world-leading, UK-based programme of international first-in-human clinical trials. In 2018 he was a recipient of the €1m Champalimaud Vision Award, and in 2020 was elected Fellow of the UK Academy of Medical Sciences. Professor Bainbridge was the previous Theme Lead for the NIHR Moorfields BRC Patient and Public Involvement / Engagement and Clinical Studies Development cross-cutting Theme.

Professor Andrew Dick

Theme Lead, Inflammation and Immunology

Andrew Dick is Duke-Elder Professor of Ophthalmology and Director of UCL Institute of Ophthalmology. His work involves basic mechanisms of immune responses in blinding disorders including age-related macular degeneration, ocular inflammation (uveitis) and experimental platforms for therapeutic development, disease stratification and molecular taxonomy of diseases.

Professor David Garway-Heath

Theme Lead, Visual Assessment and Imaging

Consultant Ophthalmic Surgeon at Moorfields Eye Hospital and International Glaucoma Association Professor for Glaucoma and Allied Studies at the UCL Institute of Ophthalmology.

Earlier this year, he was appointed president of the European Glaucoma Society (EGS), where he was previously vice president.

Professor Andrew Webster

Theme Lead, Genomic Medicine and Informatics

Andrew Webster is Chair of Molecular Ophthalmology at UCL and a Consultant Ophthalmologist at Moorfields Eye Hospital. He leads the Genetics Service at Moorfields, the largest specialist service in the country, which delivers genetic counselling, diagnosis and management for those with paediatric, retinal, optic nerve, cataract and ocular maldevelopment inherited conditions. His research team has discovered genetic mechanisms that underlie retinal dystrophies. He leads the Hearing and Sight Domain of the Genomics England Clinical Interpretation Partnership, a British national study to sequence over 100,000 genomes in those with rare disease and cancer. He trained in Ophthalmology and Genetics in Cambridge, Iowa (USA) and London.

Professor Mariya Moosajee

Theme Lead, Patient and Public Involvement/Education and Clinical Studies Development

Professor Mariya Moosajee is Professor of Molecular Ophthalmology at the UCL Institute of Ophthalmology, Group Leader of Ocular Genomics and Therapeutics at the Francis Crick Institute, and Consultant Ophthalmologist at Moorfields Eye Hospital and Great Ormond Street Hospital for Children. She specialises in genetic eye disease, providing a comprehensive genomic ophthalmology service for children and adults. She heads a research team investigating mechanisms of disease and developing novel therapeutics for treating inherited eye disorders. Professor Moosajee is a strong patient advocate, and is the creator of Gene.Vision, a web resource for patients and healthcare professionals on genetic eye disease. She is President of both the UK Eye Genetic Group and of Women in Vision UK.